EXHIBIT 10.1
XXXXXXX & CO. 1205 - 0000 Xxxx Xxxxxx Xxxxxx
----------------------------------------- Xxxxxxxxx, XX Xxxxxx
C H A R T E R E D A C C O U N T A N T S V6E 2M6
----------------------------------------- Telephone (000) 000-0000
Facsimile (000) 000-0000
Email: xxx@xxxxxxxxx.xxx
September 27, 2002
U.S. Securities and Exchange Commission
Division of Corporation Finance
000 Xxxxx Xx. X.X.
Xxxxxxxxxx XX 00000
Re: GeneMax Corp. - Form 8-K Current Report
Dear Sirs:
As chartered accountants, we hereby consent to the inclusion or incorporation by
reference in this Form 8-K Current Report Statement dated September 27, 2002, of
the following:
o Our report to the Stockholders and Board of Directors of GeneMax
Pharmaceuticals Inc. (a development stage company), dated July 24, 2002 on
the consolidated balance sheets of GeneMax Pharmaceuticals Inc. as at
December 31, 2001, 2000 and 1999 and the consolidated statements of
operations, stockholders' equity and cash flows for the years ended
December 31, 2001 and 2000, for the period from July 27, 1999 (inception)
to December 31, 1999 and for the period from July 27, 1999 (inception) to
December 31, 2001.
Yours truly,
/s/ "XxXxxxx & Co."
-------------------
XXXXXXX & CO.
Chartered Accountants
